논문 ●

• Ji Yun Lee, Ju-Hyun Lee, Woochan Park, Jeongmin Seo, Minsu Kang, Eun Hee Jung, Sang-A Kim, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang

  The Role of Direct Oral Anticoagulants in Managing Myeloproliferative Neoplasms Patients.

  Cancer Res Treat

  2024 ;57 (2) :612 -620

• Eun Hee Jung, Yusuke Hiratsuka, Sang-Yeon Suh, Seok-Joon Yoon, Beodeul Kang, Si Won Lee, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee, Yu Jung Kim

  Clinicians' Prediction of Survival Is Most Useful for Palliative Care Referral.

  Palliat Med Rep

  2024 ;5 (1) :365 -372

• Ji Yun Lee, Ju-Hyun Lee, Jeongmin Seo, Minsu Kang, Eun Hee Jung, Sang-A Kim, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee, Soo-Mee Bang

  Skeletal-Related Events in Patients With Multiple Myeloma: A Comprehensive Retrospective Cohort Study.

  J Korean Med Sci

  2024 ;39 (22) :e175 -e175

• Eunkyung Han, Hye Yeon Choi, Hyun Jung Kwon, Yul Ri Chung, Hee-Chul Shin, Eun-Kyu Kim, Koung Jin Suh, Se Hyun Kim, Jee Hyun Kim, So Yeon Park

  Characterization of tumor-infiltrating lymphocytes and their spatial distribution in triple-negative breast cancer.

  Breast Cancer Res

  2024 ;26 (1) :180 -180

• Changhee Park, Koung Jin Suh, Se Hyun Kim, Kyung-Hun Lee, Seock-Ah Im, Min Hwan Kim, Joohyuk Sohn, Jae Ho Jeong, Kyung Hae Jung, Kyoung Eun Lee, Yeon Hee Park, Hee-Jun Kim, Eun Kyung Cho, In Sil Choi, Seung-Jae Noh, Inkyung Shin, Dae-Yeon Cho, Jee Hyun Kim

  Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancer.

  Cancer Immunol Immunother

  2024 ;73 (10) :197 -197

• Songji Choi, Se Hyun Kim, Sejoon Lee, Jeongmin Seo, Minsu Kang, Eun Hee Jung, Sang-A Kim, Koung Jin Suh, Ji Yun Lee, Ji-Won Kim, Jin Won Kim, Jeong-Ok Lee, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee

  Association of TP53 Mutation Status and Sex with Clinical Outcome in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Retrospective Cohort Study.

  Cancer Res Treat

  2024 ;57 (1) :70 -82

• Seung-Been Lee, Ji-Won Kim, Hong-Geun Kim, Sung-Hyun Hwang, Kui-Jin Kim, Ju Hyun Lee, Jeongmin Seo, Minsu Kang, Eun Hee Jung, Koung Jin Suh, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Jee Hyun Kim, Nak-Jung Kwon, Keun-Wook Lee

  Longitudinal Comparative Analysis of Circulating Tumor DNA and Matched Tumor Tissue DNA in Patients with Metastatic Colorectal Cancer Receiving Palliative First-Line Systemic Anti-Cancer Therapy.

  Cancer Res Treat

  2024 ;56 (4) :1171 -1182

• Kyungah Bai, Ji Won Woo, Hyun Jung Kwon, Yul Ri Chung, Koung Jin Suh, Se Hyun Kim, Jee Hyun Kim, So Yeon Park

  Alteration of HER2 Status During Breast Cancer Progression: A Clinicopathological Analysis Focusing on HER2-Low Status.

  Lab Invest

  2024 ;104 (8) :102092 -102092

• Hyunsoon Cho, Hoejun Kwon, Se Hyun Kim, Hyung-Min Ahn, Beom K Choi, Geon Kook Lee, Seog-Yun Park, Hyun-Ju Lim, Jung-Ah Hwang, Jiyeon Lim, Ji-Youn Han, Youngjoo Lee

  Seasonal influences on the efficacy of anti-programmed cell death (ligand) 1 inhibitors in lung cancer.

  Cancer

  2024 ;130 (21) :3647 -3657

• Yu Jung Kim, Soyeon Kim, Tae Min Kim, Koung Jin Suh, Miso Kim, Se Hyun Kim, Bhumsuk Keam, Dong-Wan Kim, Jong Seok Lee, Dae Seog Heo

  A phase II study of osimertinib in patients with NSCLC harboring EGFR exon 20 insertion: A multicenter trial of the Korean Cancer Study Group (LU17-19).

  Lung Cancer

  2024 ;194 :107870 -107870

• Ji Won Woo, Eun Kyung Han, Koung Jin Suh, Se Hyun Kim, Jee Hyun Kim, So Yeon Park

  Alteration of PD-L1 (SP142) status after neoadjuvant chemotherapy and its clinical significance in triple-negative breast cancer.

  Breast Cancer Res Treat

  2024 ;207 (2) :301 -311

• Soojung Hong, Ju Hyun Lee, Ja Yoon Heo, Koung Jin Suh, Se Hyun Kim, Yu Jung Kim, Jee Hyun Kim

  Impact of concurrent medications on clinical outcomes of cancer patients treated with immune checkpoint inhibitors: analysis of Health Insurance Review and Assessment data.

  J Cancer Res Clin Oncol

  2024 ;150 (4) :186 -186

• Jayesh Desai, Guzman Alonso, Se Hyun Kim, Andres Cervantes, Thomas Karasic, Laura Medina, Einat Shacham-Shmueli, Rasha Cosman, Alejandro Falcon, Eelke Gort, Tormod Guren, Erminia Massarelli, Wilson H Miller, Luis Paz-Ares, Hans Prenen, Alessio Amatu, Chiara Cremolini, Tae Won Kim, Victor Moreno, Sai-Hong I Ou, Alessandro Passardi, Adrian Sacher, Armando Santoro, Rafal Stec, Susanna Ulahannan, Kathryn Arbour, Patricia Lorusso, Jia Luo, Manish R Patel, Yoonha Choi, Zhen Shi, Sandhya Mandlekar, Mark T Lin, Stephanie Royer-Joo, Julie Chang, Tomi Jun, Neekesh V Dharia, Jennifer L Schutzman, GO42144 Investigator and Study Group, Sae-Won Han

  Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial.

  Nat Med

  2024 ;30 (1) :271 -278

• Songji Choi, Seyoung Seo, Ju Hyun Lee, Koung Jin Suh, Ji-Won Kim, Jin Won Kim, Se Hyun Kim, Yu Jung Kim, Keun-Wook Lee, Jwa Hoon Kim, Tae Won Kim, Yong Sang Hong, Sun Young Kim, Jeong Eun Kim, Sang-We Kim, Dae Ho Lee, Jae Cheol Lee, Chang-Min Choi, Shinkyo Yoon, Su-Jin Koh, Young Joo Min, Yongchel Ahn, Hwa Jung Kim, Jin Ho Baek, Sook Ryun Park, Jee Hyun Kim

  Impact of Patient Sex on Adverse Events and Unscheduled Utilization of Medical Services in Cancer Patients Undergoing Adjuvant Chemotherapy: A Multicenter Retrospective Cohort Study.

  Cancer Res Treat

  2024 ;56 (2) :404 -413

• Eun Kyung Han, Ji Won Woo, Koung Jin Suh, Se Hyun Kim, Jee Hyun Kim, So Yeon Park

  PD-L1 (SP142) Expression in Primary and Recurrent/Metastatic Triple-Negative Breast Cancers and Its Clinicopathological Significance.

  Cancer Res Treat

  2024 ;56 (2) :557 -566

• Seon-Hye Won, Yusuke Hiratsuka, Sang-Yeon Suh, Hayoung Bae, Sung-Eun Choi, Yu Jung Kim, Beodeul Kang, Si Won Lee, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee

  Mid-upper Arm Circumference as an Indicator of Quality of Life of Patients with Advanced Cancer.

  J Palliat Care

  2023 ;38 (1) :24 -29

• Kyeonghui Kim, Hyemin Kim, Inkyung Shin, Seung-Jae Noh, Jeong Yeon Kim, Koung Jin Suh, Yoo-Na Kim, Jung-Yun Lee, Dae-Yeon Cho, Se Hyun Kim, Jee Hyun Kim, Se-Hoon Lee, Jung Kyoon Choi

  Genomic hypomethylation in cell-free DNA predicts responses to checkpoint blockade in lung and breast cancer.

  Sci Rep

  2023 ;13 (1) :22482 -22482

• Sun-Wook Kim, Jung Hun Ohn, Nak-Hyun Kim, Eun Sun Kim, Yejee Lim, Jongchan Lee, Hye Won Kim, Jiwon Ryu, Hee-Sun Park, Koung Jin Suh, Ji-Won Kim, Jin Won Kim, Se Hyun Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee, Hak Chul Jang

  The Hospitalist-Oncologist co-ManagemEnt (HOME) system improves hospitalization outcomes of patients with cancer.

  BMC Health Serv Res

  2023 ;23 (1) :1367 -1367

• Se Hyun Kim, Seock-Ah Im, Koung Jin Suh, Kyung-Hun Lee, Min Hwan Kim, Joohyuk Sohn, Yeon Hee Park, Ji-Yeon Kim, Jae Ho Jeong, Kyoung Eun Lee, In Sil Choi, Kyong Hwa Park, Hee-Jun Kim, Eun Kyung Cho, So Yeon Park, Milim Kim, Jee Hyun Kim

  Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16).

  Eur J Cancer

  2023 ;195 (0) :113386 -113386

• Sheehyun Kim, Sungjae Kim, Se Hyun Kim, Eun Hee Jung, Koung Jin Suh, Yu Jung Kim, Nak-Jung Kwon, Hyojin Kim, Jin-Haeng Chung, Jong Seok Lee

  Clinical validity of oncogenic driver genes detected from circulating tumor DNA in the blood of lung cancer patients.

  Transl Lung Cancer Res

  2023 ;12 (6) :1185 -1196

• Hyejo Ryu, Changhoon Song, Jae-Sung Kim, Jae Hyun Jeon, Sukki Cho, Kwhanmien Kim, Sanghoon Jheon, Se Hyun Kim, Yu Jung Kim, Jong Seok Lee

  Role of prognostic nutritional index in postoperative radiotherapy for non-small cell lung cancer.

  Thorac Cancer

  2023 ;14 (28) :2859 -2868

• Ji-Jung Jung, Eun-Kyu Kim, Eunyoung Kang, Jee Hyun Kim, Se Hyun Kim, Koung Jin Suh, Sun Mi Kim, Mijung Jang, Bo La Yun, So Yeon Park, Changjin Lim, Wonshik Han, Hee-Chul Shin

  Development and External Validation of a Machine Learning Model to Predict Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer.

  J Breast Cancer

  2023 ;26 (4) :353 -362

• Jieun Yang, Se Hyun Kim, Eun Hee Jung, Sang-A Kim, Koung Jin Suh, Ji Yun Lee, Ji-Won Kim, Jin Won Kim, Jeong-Ok Lee, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee

  The effect of metformin or dipeptidyl peptidase 4 inhibitors on clinical outcomes in metastatic non-small cell lung cancer treated with immune checkpoint inhibitors.

  Thorac Cancer

  2023 ;14 (1) :52 -60

• Hyojin Kim, Hyun Jung Kwon, Eun Sun Kim, Soohyeon Kwon, Kyoung Jin Suh, Se Hyun Kim, Yu Jung Kim, Jong Seok Lee, Jin-Haeng Chung

  Comparison of the Predictive Power of a Combination versus Individual Biomarker Testing in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.

  Cancer Res Treat

  2022 ;54 (2) :424 -433

• Yusuke Hiratsuka, Yu Jung Kim, Sang-Yeon Suh, Seon Hye Won, Sung Eun Choi, Thomas W LeBlanc, Beodeul Kang, Si Won Lee, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee

  The association between changes in symptoms or quality of life and overall survival in outpatients with advanced cancer.

  Ann Palliat Med

  2022 ;11 (7) :2338 -2348

• Jwa Hoon Kim, Seyoung Seo, Jee Hyun Kim, Su-Jin Koh, Yongchel Ahn, Kyung Hae Jung, Jin-Hee Ahn, Sung-Bae Kim, Tae Won Kim, Yong Sang Hong, Sun Young Kim, Jeong Eun Kim, Sang-We Kim, Dae Ho Lee, Jae Cheol Lee, Chang-Min Choi, Shinkyo Yoon, Jae Ho Jeong, Hwa Jung Kim, Koung Jin Suh, Se Hyun Kim, Yu Jung Kim, Young Joo Min, Jin Ho Baek, Sook Ryun Park

  The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study.

  Cancer Med

  2022 ;11 (3) :705 -714

• Yu Jung Kim, Yusuke Hiratsuka, Sang-Yeon Suh, Beodeul Kang, Si Won Lee, Hong-Yup Ahn, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee

  A Prognostic Model to Facilitate Palliative Care Referral in Oncology Outpatients.

  Cancer Res Treat

  2022 ;54 (2) :621 -629

• Jung Sun Kim, Koung Jin Suh, Dae-Won Lee, Go-Un Woo, Miso Kim, Se Hyun Kim, Han Suk Ryu, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, So Yeon Park, In Ae Park, Jee Hyun Kim, Seock-Ah Im

  A Real-world Efficacy of Nab-paclitaxel Monotherapy in Metastatic Breast Cancer.

  Cancer Res Treat

  2022 ;54 (2) :488 -496

• Ji Yun Lee, Ju-Hyun Lee, Sang-A Kim, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee, Soo-Mee Bang

  Treatment patterns of thrombopoietin receptor agonists among adults with primary immune thrombocytopenia: A Korean nationwide population-based study.

  Thromb Res

  2022 ;213 :114 -118

• Minsu Kang, Hee Young Na, Soomin Ahn, Ji-Won Kim, Sejoon Lee, Soyeon Ahn, Ju Hyun Lee, Jeonghwan Youk, Haesook T Kim, Kui-Jin Kim, Koung Jin Suh, Jun Suh Lee, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Yoo-Seok Yoon, Jee Hyun Kim, Jin-Haeng Chung, Ho-Seong Han, Jong Seok Lee

  Gallbladder adenocarcinomas undergo subclonal diversification and selection from precancerous lesions to metastatic tumors.

  Elife

  2022 ;11

• Yu Jung Kim, Yusuke Hiratsuka, Sang-Yeon Suh, Seon-Hye Won, Eun Hee Jung, Beodeul Kang, Si Won Lee, Hong-Yup Ahn, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee

  Performance of mid-upper arm circumference and other prognostic indices based on inflammation and nutrition in oncology outpatients: a tertiary cancer center study.

  Ann Palliat Med

  2022 ;11 (10) :3171 -3180

• Song Yi Park, Koung Jin Suh, Dae-Won Lee, Han Suk Ryu, Miso Kim, Se Hyun Kim, Kyung-Hun Lee, Tae-Yong Kim, Jee Hyun Kim, In Ae Park, Seock-Ah Im

  Prognostic role of tumor subtype and germline BRCA mutation in advanced breast cancer patients treated with palbociclib plus endocrine therapy.

  Breast Cancer Res Treat

  2022 ;196 (1) :121 -128

• Eun Hee Jung, Si Won Lee, Yu Jung Kim, Beodeul Kang, Koung Jin Suh, Ju Hyun Lee, Esther Jeon, Dahee Kim, Sung Soun Hur, Ji Yun Lee, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Jeong-Ok Lee, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee, Eduardo Bruera

  Clinical Outcomes of Operating an Acute Palliative Care Unit at a Comprehensive Cancer Center.

  JCO Oncol Pract

  2022 ;18 (10) :e1661 -e1671

• Nobuyuki Takahashi, Sehyun Kim, Christopher W Schultz, Vinodh N Rajapakse, Yang Zhang, Christophe E Redon, Haiqing Fu, Lorinc Pongor, Suresh Kumar, Yves Pommier, Mirit I Aladjem, Anish Thomas

  Replication stress defines distinct molecular subtypes across cancers.

  Cancer Res Commun

  2022 ;2 (6) :503 -517

• Yu Jung Kim, Seok Joon Yoon, Sang-Yeon Suh, Yusuke Hiratsuka, Beodeul Kang, Si Won Lee, Hong-Yup Ahn, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Keun-Wook Lee, Jee Hyun Kim, Jong Seok Lee

  Performance of clinician prediction of survival in oncology outpatients with advanced cancer.

  PLoS One

  2022 ;17 (4) :e0267467 -e0267467

• Sehhoon Park, Chan-Young Ock, Hyojin Kim, Sergio Pereira, Seonwook Park, Minuk Ma, Sangjoon Choi, Seokhwi Kim, Seunghwan Shin, Brian Jaehong Aum, Kyunghyun Paeng, Donggeun Yoo, Hongui Cha, Sunyoung Park, Koung Jin Suh, Hyun Ae Jung, Se Hyun Kim, Yu Jung Kim, Jong-Mu Sun, Jin-Haeng Chung, Jin Seok Ahn, Myung-Ju Ahn, Jong Seok Lee, Keunchil Park, Sang Yong Song, Yung-Jue Bang, Yoon-La Choi, Tony S Mok, Se-Hoon Lee

  Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer.

  J Clin Oncol

  2022 ;40 (17) :1916 -1928

• Joonha Kwon, Jun Hyeong Lee, Young Han Lee, Jeeyun Lee, Jin-Hee Ahn, Se Hyun Kim, Seung Hyun Kim, Tae Il Kim, Kum-Hee Yun, Young Suk Park, Jeong Eun Kim, Kyu Sang Lee, Jung Kyoon Choi, Hyo Song Kim

  Whole-Genome and Transcriptome Sequencing Identified NOTCH2 and HES1 as Potential Markers of Response to Imatinib in Desmoid Tumor (Aggressive Fibromatosis): A Phase II Trial Study.

  Cancer Res Treat

  2022 ;54 (4) :1240 -1255

• Minsu Kang, Koung Jin Suh, Ji-Won Kim, Ja Min Byun, Jin Won Kim, Ji Yun Lee, Jeong-Ok Lee, Soo-Mee Bang, Yu Jung Kim, Se Hyun Kim, Jee Hyun Kim, Jong Seok Lee, Keun-Wook Lee

  Clinical characteristics and disease course of splanchnic vein thrombosis in gastrointestinal cancers: A prospective cohort study.

  PLoS One

  2022 ;17 (1) :e0261671 -e0261671

• In Gyu Hwang, Minsuk Kwon, Jin Won Kim, Se Hyun Kim, Yun-Gyoo Lee, Jin Young Kim, Su-Jin Koh, Yoon Ho Ko, Seong Hoon Shin, Soojung Hong, Tae-Yong Kim, Sun Young Kim, Hyun Jung Kim, Hyo Jung Kim, Myung Ah Lee, Jung Hye Kwon, Yong Sang Hong, Kyung Hee Lee, Sung Hwa Bae, Dong-Hoe Koo, Jee Hyun Kim, In Sook Woo

  Prevalence and Predictive Factors for Upfront Dose Reduction of the First Cycle of First-Line Chemotherapy in Older Adults with Metastatic Solid Cancer: Korean Cancer Study Group (KCSG) Multicenter Study.

  Cancers (Basel)

  2021 ;13 (2)

• Changhee Park, Miso Kim, Yoonjin Kwak, Kyung Chul Moon, Se Hyun Kim, Bhumsuk Keam, Yu Jung Kim, Tae Min Kim, Dong-Wan Kim

  Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma who Received Systemic Treatment.

  Cancer Res Treat

  2021 ;53 (4) :1195 -1203

• Sang-A Kim, Hyejoo Park, Kui-Jin Kim, Ji-Won Kim, Ji Hea Sung, Milang Nam, Ju Hyun Lee, Eun Hee Jung, Koung Jin Suh, Ji Yun Lee, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee, Keun-Wook Lee

  Amphiregulin can predict treatment resistance to palliative first-line cetuximab plus FOLFIRI chemotherapy in patients with RAS wild-type metastatic colorectal cancer.

  Sci Rep

  2021 ;11 (1) :23803 -23803

• Kyung-Hwak Yoon, Yeshong Park, Eunyoung Kang, Eun-Kyu Kim, Jee Hyun Kim, Se Hyun Kim, Koung Jin Suh, Sun Mi Kim, Mijung Jang, Bo La Yun, So Yeon Park, Hee-Chul Shin

  Effect of Estrogen Receptor Expression Level and Hormonal Therapy on Prognosis of Early Breast Cancer.

  Cancer Res Treat

  2021

• Ukhyun Jo, Ilya S Senatorov, Astrid Zimmermann, Liton Kumar Saha, Yasuhisa Murai, Se Hyun Kim, Vinodh N Rajapakse, Fathi Elloumi, Nobuyuki Takahashi, Christopher W Schultz, Anish Thomas, Frank T Zenke, Yves Pommier

  Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents.

  Mol Cancer Ther

  2021 ;20 (8) :1431 -1441

• Eun Hee Jung, Hee Ryeong Jang, Se Hyun Kim, Koung Jin Suh, Yu Jung Kim, Ju-Hyun Lee, Jin-Haeng Chung, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo, Jong Seok Lee

  Tumor LAG-3 and NY-ESO-1 expression predict durable clinical benefits of immune checkpoint inhibitors in advanced non-small cell lung cancer.

  Thorac Cancer

  2021 ;12 (5) :619 -630

• Minsu Kang, Changhee Park, Se Hyun Kim, Sock Won Yoon, Koung Jin Suh, Yu Jung Kim, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo, Jong Seok Lee

  Programmed death-ligand 1 expression level as a predictor of EGFR tyrosine kinase inhibitor efficacy in lung adenocarcinoma.

  Transl Lung Cancer Res

  2021 ;10 (2) :699 -711

• Ja Yoon Heo, Shin Hye Yoo, Koung Jin Suh, Se Hyun Kim, Yu Jung Kim, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo, Jong Seok Lee

  Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients.

  Sci Rep

  2021 ;11 (1) :2514 -2514

• Ji Yun Lee, Minsu Kang, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Kyoung-Ho Song, Eu Suk Kim, Hong Bin Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong-Seok Lee, Jeong-Ok Lee

  Pneumocystis jirovecii pneumonia in diffuse large B-cell Lymphoma treated with R-CHOP.

  Mycoses

  2021 ;64 (1) :60 -65

• Anish Thomas, Nobuyuki Takahashi, Vinodh N Rajapakse, Xiaohu Zhang, Yilun Sun, Michele Ceribelli, Kelli M Wilson, Yang Zhang, Erin Beck, Linda Sciuto, Samantha Nichols, Brian Elenbaas, Janusz Puc, Heike Dahmen, Astrid Zimmermann, Jillian Varonin, Christopher W Schultz, Sehyun Kim, Hirity Shimellis, Parth Desai, Carleen Klumpp-Thomas, Lu Chen, Jameson Travers, Crystal McKnight, Sam Michael, Zina Itkin, Sunmin Lee, Akira Yuno, Min-Jung Lee, Christophe E Redon, Jessica D Kindrick, Cody J Peer, Jun S Wei, Mirit I Aladjem, William Douglas Figg, Seth M Steinberg, Jane B Trepel, Frank T Zenke, Yves Pommier, Javed Khan, Craig J Thomas

  Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress.

  Cancer Cell

  2021 ;39 (4) :566 -579.e7

• Anish Thomas, Idrees Mian, Camille Tlemsani, Lorinc Pongor, Nobuyuki Takahashi, Kathleen Maignan, Jeremy Snider, Gerald Li, Garrett Frampton, Siraj Ali, Sehyun Kim, Samantha Nichols, Vinodh Rajapakse, Udayan Guha, Elad Sharon, Junya Fujimoto, Cesar A Moran, Ignacio I Wistuba, Jun S Wei, Javed Khan, Eva Szabo, Aracelis Z Torres, Kenneth R Carson

  Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers: Results From a Retrospective Multicenter Cohort Study.

  Chest

  2020 ;158 (4) :1723 -1733

• Soojung Hong, Ju Hyun Lee, Eun Kyeong Chun, Kwang-Il Kim, Jin Won Kim, Se Hyun Kim, Yun-Gyoo Lee, In Gyu Hwang, Jin Young Kim, Su-Jin Koh, Yoon Ho Ko, Seong Hoon Shin, In Sook Woo, Tae-Yong Kim, Ji Yeon Baek, Hyun Jung Kim, Hyo Jung Kim, Myung Ah Lee, Jung Hye Kwon, Yong Sang Hong, Hun-Mo Ryoo, Jee Hyun Kim

  Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.

  Oncologist

  2020 ;25 (3) :e502 -e511

• Grace S Ahn, Hak Ro Kim, Beodeul Kang, Sung Soun Hur, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Jeong-Ok Lee, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee, Yu Jung Kim

  Symptom burden and characteristics of patients who die in the acute palliative care unit of a tertiary cancer center.

  Ann Palliat Med

  2020 ;9 (2) :216 -223

• Hyun Jung Lee, Kui-Jin Kim, Ji Hea Sung, Milang Nam, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jong Seok Lee, Jee Hyun Kim

  PI3K p110α Blockade Enhances Anti-Tumor Efficacy of Abemaciclib in Human Colorectal Cancer Cells.

  Cancers (Basel)

  2020 ;12 (9)

• Se Hyun Kim, Soomin Ahn, Koung Jin Suh, Yu Jung Kim, So Yeon Park, Eunyoung Kang, Eun-Kyu Kim, In Ah Kim, Sumin Chae, Murim Choi, Jee Hyun Kim

  Identifying germline APOBEC3B deletion and immune phenotype in Korean patients with operable breast cancer.

  Breast Cancer Res Treat

  2020 ;183 (3) :697 -704

• Miso Kim, Bhumsuk Keam, Chan-Young Ock, Se Hyun Kim, Yu Jung Kim, Sun Min Lim, Jin-Soo Kim, Tae Min Kim, Sook-Hee Hong, Mi Sun Ahn, Seong Hoon Shin, Eun Joo Kang, Dong-Wan Kim, Sun-Wha Im, Jong-Il Kim, Jong Seok Lee, Joo-Hang Kim, Dae Seog Heo

  Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG-LU16-07.

  Thorac Cancer

  2020 ;11 (12) :3482 -3489

• Soomin Ahn, Hyun Jeong Kim, Eunyoung Kang, Eun-Kyu Kim, Se Hyun Kim, Jee Hyun Kim, In Ah Kim, So Yeon Park

  Genomic profiling of multiple breast cancer reveals inter-lesional heterogeneity.

  Br J Cancer

  2020 ;122 (5) :697 -704

• KIM SE HYUN, Keam Bhumsuk, Moon Song Mi, Kang Chang Kyung, Jun Kang Il, Suh Koung Jin, Lee Dae-Won, Ock Chan-Young, Kim Miso, Choi Yunhee, Lim Yoojoo, Lee Kyung-Hun, Kim Tae Min, Kim Tae-Yong, Oh Do-Youn, Kim Dong-Wan, Im Seock-Ah, Lee Jong Seok, Kim Eu Suk, Kim Hong Bin, Kim Nam-Joong, Kim Yu Jung, Park Wan Beom, Oh Myoung-Don

  Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint Inhibitors

  Clin. Infect. Dis.

  2020 ;71 (2) :422 -425

• Bhumsuk Keam, Chang Kyung Kang, Kang Il Jun, Song Mi Moon, Koung Jin Suh, Dae-Won Lee, Chan-Young Ock, Miso Kim, Yunhee Choi, Yoojoo Lim, Kyung-Hun Lee, Se Hyun Kim, Tae Min Kim, Tae-Yong Kim, Do-Youn Oh, Dong-Wan Kim, Seock-Ah Im, Jong Seok Lee, Eu Suk Kim, Hong Bin Kim, Nam-Joong Kim, Yu Jung Kim, Wan Beom Park, Myoung-Don Oh

  Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint Inhibitors.

  Clin Infect Dis

  2020 ;71 (2) :422 -425

• Kim Dong-Yun, Song Changhoon, Kim Se Hyun, Kim Yu Jung, Lee Jong Seok, Kim Jae-Sung

  Chemoradiotherapy versus radiotherapy alone following induction chemotherapy for elderly patients with stage III lung cancer

  Radiat Oncol J

  2019 ;37 (3) :176 -184

• Kim Ji-Yeon, Park Seri, Im Seock-Ah, Kim Sung-Bae, Sohn Joohyuk, Lee Keun Seok, Chae Yee Soo, Lee Ki Hyeong, Kim Jee Hyun, Im Young-Hyuck, Kim Tae-Yong, Lee Kyung-Hun, Ahn Jin-Hee, Kim Gun Min, Park In Hae, Lee Soo Jung, Han Hye Sook, Kim Se Hyun, Jung Kyung Hae, Park Yeon Hee,

  Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11)

  CANCER COMMUN

  2019 ;39 (1)

• Lee Jeong-Ok, Bang Soo-Mee, Lee Ji Yun, Chun Eun Ju, Choi Sang Il, Kim Jin Won, Kim Se Hyun, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Lee Jong Seok

  Incidence and predictors of venous thromboembolism in medically ill hospitalized elderly cancer patients: a prospective observational study

  SUPPORT CARE CANCER

  2019 ;27 (7) :2507 -2515

• Kwon Ji-Hyun, Kim Kui-Jin, Sung Ji Hea, Suh Koung Jin, Lee Ji Yun, Kim Ji-Won, Kim Se Hyun, Lee Jeong-Ok, Kim Jin Won, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee, Kim Soyeon, Yoon Sung-Soo, Lee Jong Seok

  Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement

  CELLS-BASEL

  2019 ;8 (12)

• Heo Ja Yoon, Park Changhee, Keam Bhumsuk, Ock Chan-Young, Kim Miso, Kim Tae Min, Kim Dong-Wan, Kim Se Hyun, Kim Yu Jung, Lee Jong Seok, Heo Dae Seog

  The efficacy of immune checkpoint inhibitors in anaplastic lymphoma kinase-positive non-small cell lung cancer

  THORAC CANCER

  2019 ;10 (11) :2117 -2123

• Woo Ji Won, Chung Yul Ri, Ahn Soomin, Kang Eunyoung, Kim Eun-Kyu, Kim Se Hyun, Kim Jee Hyun, Kim In Ah, Park So Yeon

  Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value

  J BREAST CANCER

  2019 ;22 (3) :439 -452

• Kim Hyojin, Kwon Hyun Jung, Han Yeon Bi, Park Soo Young, Kim Eun Sun, Kim Se Hyun, Kim Yu Jung, Lee Jong Seok, Chung Jin-Haeng

  Increased CD3+ T cells with a low FOXP3+/CD8+ T cell ratio can predict anti-PD-1 therapeutic response in non-small cell lung cancer patients

  MODERN PATHOL

  2019 ;32 (3) :367 -375

• Choi Yeonjoo, Kim Jin Won, Suh Koung Jin, Lim Yoo-Joo, Lee Ji Yun, Kang Beo-Deul, Kim Ji-Won, Kim Se-Hyun, Lee Jeong-Ok, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee, Lee Jong Seok

  Identification of a potentially avoidable cardiopulmonary resuscitation in hematology and oncology wards

  BMC PALLIAT CARE

  2019 ;18 (1)

• Kim Jin Won, Kim Se Hyun, Lee Yun-Gyoo, Hwang In Gyu, Kim Jin Young, Koh Su-Jin, Ko Yoon Ho, Shin Seong Hoon, Woo In Sook, Hong Soojung, Kim Tae-Yong, Baek Ji Yeon, Kim Hyun Jung, Kim Hyo Jung, Lee Myung Ah, Kwon Jung Hye, Hong Yong Sang, Ryoo Hun-Mo, Lee Kyung Hee, Kim Jee Hyun

  Prospective Validation of The Korean Cancer Study Group Geriatric Score (KG)-7, a Novel Geriatric Screening Tool, in Older Patients with Advanced Cancer Undergoing First-line Palliative Chemotherapy

  CANCER RES TREAT

  2019 ;51 (3) :1249 -1256

• Kim Ryul, Keam Bhumsuk, Kim Sehui, Kim Miso, Kim Se Hyun, Kim Jin Wook, Kim Yu Jung, Kim Tae Min, Jeon Yoon Kyung, Kim Dong-Wan, Chung Doo Hyun, Lee Jong Seok, Heo Dae Seog

  Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors

  BMC CANCER

  2019 ;19 (1)

• Kim Yu-Jung, Keam Bhumsuk, Ock Chan-Young, Song Sanghoon, Kim Miso, Kim Se Hyun, Kim Ki Hwan, Kim Jin-Soo, Kim Tae Min, Kim Dong-Wan, Lee Jong Seok, Heo Dae Seog

  A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancer

  LUNG CANCER

  2019 ;136 (3) :122 -128

• Shin Junghoon, Chung Jin-Haeng, Kim Se Hyun, Lee Kyu Sang, Suh Koung Jin, Lee Ji Yun, Kim Ji-Won, Lee Jeong-Ok, Kim Jin-Won, Kim Yu-Jung, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee, Lee Jong-Seok

  Effect of Platinum-Based Chemotherapy on PD-L1 Expression on Tumor Cells in Non-small Cell Lung Cancer

  CANCER RES TREAT

  2019 ;51 (3) :1086 -1097

• Kim Se Hyun, Kim Jin Won, Hwang In Gyu, Jang Joung Soon, Hong Soojung, Kim Tae-Yong, Baek Ji Yeon, Shin Seong Hoon, Sun Der Sheng, Hong Dae-Sik, Kim Hyo Jung, Hong Yong Sang, Woo In Sook, Lee Ju-Hyun, Kim Jee Hyun

  Serum biomarkers for predicting overall survival and early mortality in older patients with metastatic solid tumors

  J GERIATR ONCOL

  2019 ;10 (5) :749 -756

• Chae S, Kim E K, Kang K M, Kim H J, Kang E, Park S Y, Kim J H, Kim S H, Kim S W

  Neutrophil-lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer

  CURR ONCOL

  2018 ;25 (2) :e113 -e119

• Cho Jun Yeun, Park Jong Sun, Kim Junghoon, Lee Jong Seok, Kim Yu Jung, Kim Se Hyun, Lee Yeon Joo, Cho Young-Jae, Yoon Ho Il, Lee Jae Ho, Lee Choon-Taek

  Characteristics, incidence, and risk factors of immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer

  LUNG CANCER

  2018 ;125 :150 -156

• Choi In Sil, Lee Keun-Wook, Kim Jee Hyun, Lee Ju Hyun, Suh Koung Jin, Lee Ji Yun, Kim Ji-Won, Kim Se-Hyun, Kim Jin Won, Lee Jeong-Ok, Kim Yu Jung, Bang Soo-Mee, Lee Jong Seok

  A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database study

  PLOS ONE

  2018 ;13 (10)

• Ryu Haram, Kim Kui-Jin, Rha Sun Young, Kim Se Hyun, Ock Chan-Young, Suh Koung Jin, Lee Ji Yun, Kim Ji-Won, Lee Jeong-Ok, Kim Jin Won, Kim Yu Jung, Lee Keun-Wook, Bang Soo-Mee, Kim Jee Hyun, Lee Jong Seok, Ahn Joong Bae

  BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression

  INT J MOL SCI

  2018 ;19 (10)

• Ahn Soomin, Park So Yeon, Kim Hyun Jeong, Kim Milim, Chung Yul Ri, Kang Eunyoung, Kim Eun-Kyu, Kim Se Hyun, Kim Yu Jung, Kim Jee Hyun, Kim In Ah

  Negative Conversion of Progesterone Receptor Status after Primary Systemic Therapy Is Associated with Poor Clinical Outcome in Patients with Breast Cancer

  CANCER RES TREAT

  2018 ;50 (4) :1418 -1432

• Kim Se Hyun, Park Kyu Hyun, Shin Sang Joon, Lee Kang Young, Kim Tae Il, Kim Nam Kyu, Rha Sun Young, Ahn Joong Bae

  CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer

  YONSEI MED J

  2018 ;59 (5) :588 -594

• Shin Junghoon, Kim Se Hyun, Lee Kyu Sang, Yoh Kyung Ah, Cho Hyun Jin, Choi Moon Ki, Kim Yu Jung, Chung Jin-Haeng, Cho Sukki, Kim Kwhanmien, Jheon Sanghoon, Yoon Ho Il, Lee Jae Ho, Lee Choon-Taek, Lee Jong Seok

  Prognostic Impact of DNA Repair Protein Expression in Non-Small Cell Lung Cancers Treated with Platinum-Based Chemotherapy and Subsequent Curative Lung Resection

  ONCOLOGY-BASEL

  2018 ;95 (1) :20 -30

• Jo Jaemin, Kim Se Hyun, Kim Yu Jung, Lee Juhyun, Kim Miso, Keam Bhumsuk, Kim Tae Min, Kim Dong Wan, Heo Dae Seog, Chung Jin Haeng, Jeon Yoon Kyung, Lee Jong Seok

  Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung Cancer

  YONSEI MED J

  2018 ;59 (2) :202 -210

• Suh Koung Jin, Kim Se Hyun, Kim Yu Jung, Kim Miso, Keam Bhumsuk, Kim Tae Min, Kim Dong-Wan, Heo Dae Seog, Lee Jong Seok

  Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody

  CANCER IMMUNOL IMMUN

  2018 ;67 (3) :459 -470

• Lee Keun-Wook, Lee Dae Ho, Kang Jin Hyoung, Park Joon Oh, Kim Se Hyun, Hong Yong Sang, Kim Seung Tae, Oh Do-Youn, Bang Yung-Jue

  Phase I Pharmacokinetic Study of Nivolumab in Korean Patients with Advanced Solid Tumors

  ONCOLOGIST

  2018 ;23 (2) :155 -e17

• Kim Tackeun, Kim Chae-Yong, Song Changhoon, Han Jung Ho, Kim In-Ah, Kim Yu Jung, Kim Se Hyun, Kim Jee Hyun

  Epidemiology of Intracranial Metastases in Korea: A National Cohort Investigation

  CANCER RES TREAT

  2018 ;50 (1) :164 -174

• Yoo Shin Hye, Keam Bhumsuk, Kim Miso, Kim Se Hyun, Kim Yu Jung, Kim Tae Min, Kim Dong-Wan, Lee Jong Seok, Heo Dae Seog

  Low-dose nivolumab can be effective in non-small cell lung cancer: alternative option for financial toxicity

  ESMO Open

  2018 ;3 (5)

• Park Jin Hyun, Choi In Sil, Kim Ki Hwan, Kim Jin-Soo, Lee Kyung-Hun, Kim Tae-Yong, Im Seock-Ah, Kim Se Hyun, Kim Yu Jung, Kim Jee Hyun

  Treatment Patterns and Outcomes in Elderly Patients with Metastatic Breast Cancer: A Multicenter Retrospective Study

  J BREAST CANCER

  2017 ;20 (4) :368 -377

• Park Yeon Hee, Im Seock-Ah, Kim Sung-Bae, Sohn Joo Hyuk, Lee Keun Seok, Chae Yee Soo, Lee Ki Hyeong, Kim Jee Hyun, Im Young-Hyuck, Kim Ji-Yeon, Kim Tae-Yong, Lee Kyung-Hun, Ahn Jin-Hee, Kim Gun Min, Park In Hae, Lee Soo Jung, Han Hye Sook, Kim Se Hyun, Jung Kyung Hae,

  Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer

  EUR J CANCER

  2017 ;86 :385 -393

• Suh Koung Jin, Kim Jin Won, Sung Ji Hea, Han Song-Hee, Lee Hye Seung, Min Ahrum, Kang Mi Hyun, Kim Ji Eun, Kim Ji-Won, Kim Se Hyun, Lee Jeong-Ok, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee, Im Seock-Ah, Lee Jong Seok

  EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release

  Oncotarget

  2017 ;8 (38) :63901 -63910

• Lee June-Koo, Kim Tae Min, Ju Young Seok, Lee Junehawk, Kim Sehui, Kim Soyeon, Youk Jeonghwan, Park Seongyeol, An Yohan, Keam Bhumsuk, Kim Dong-Wan, Heo Dae Seog, Kim Young Tae, Kim Jin-Soo, Kim Se Hyun, Lee Jong Seok, Lee Se-Hoon, Park Keunchil, Ku Ja-Lok, Jeon Yoon Kyung, Chung Doo Hyun, Park Peter J, Kim Joon

  Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas

  J CLIN ONCOL

  2017 ;35 (26) :3065 -3074

• Lee Ji Yun, Bang Soo-Mee, Lee Ju-Hyun, Lee Heeyoung, Kang Beodeul, Kim Ji-Won, Kim Se Hyun, Lee Jeong-Ok, Kim Jin Won, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Choi Hyoung Soo, Lee Jong Seok

  Epidemiology and management of primary immune thrombocytopenia: A nationwide population-based study in Korea

  THROMB RES

  2017 ;155 :86 -91

• Lim Sung Hee, Park Keunchil, Yoh Kyung Ah, Lee Jong Seok, Ahn Myung-Ju, Kim Yu Jung, Kim Se Hyun, Zhang Jie, Patel Dony, Swallow Elyse, Kageleiry Andrew, Galebach Philip, Lee Dongyeol, Stein Karen, Degun Ravi

  Characteristics and outcomes of ALK+ non-small cell lung cancer patients in Korea

  ASIA-PAC J CLIN ONCO

  2017 ;13 (5) :e239 -e245

• Lee Jong Seok, Kim Se Hyun, Kim Mi-Jung, Kim Yu Jung, Chang Hyun, Kim Jin Won, Lee Jeong-Ok, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee

  Paclitaxel as third-line chemotherapy for small cell lung cancer failing both etoposide- and camptothecin-based chemotherapy

  MEDICINE

  2017 ;96 (42)

• Lim Yu Jin, Kim In Ah, Lee Sea-Won, Choi Noorie, Kwon Jeanny, Eom Keun-Yong, Kang Eunyoung, Kim Eun-Kyu, Kim Sung-Won, Kim Jee Hyun, Kim Yu Jung, Kim Se Hyun, Park So Yeon, Kim Jae-Sung

  Failure patterns according to molecular subtype in patients with invasive breast cancer following postoperative adjuvant radiotherapy: long-term outcomes in contemporary clinical practice

  BREAST CANCER RES TR

  2017 ;163 (3) :555 -563

• Suh Koung Jin, Kim Jee Hyun, Kim Se Hyun, Lee Kyung-Hun, Kim Tae-Yong, Kim Yu Jung, Han Sae-Won, Kang Eunyoung, Kim Eun-Kyu, Kim Kidong, No Jae Hong, Han Wonshik, Noh Dong-Young, Lee Maria, Kim Hee Seung, Im Seock-Ah

  Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors

  CANCER RES TREAT

  2017 ;49 (4) :1153 -1163

• Kim Se Hyun, Park Kyu Hyun, Shin Sang Joon, Lee Kang Young, Kim Tae Il, Kim Nam Kyu, Rha Sun Young, Roh Jae Kyung, Ahn Joong Bae

  p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer

  CANCER RES TREAT

  2016 ;48 (1) :208 -215

• Cho Kyoung-Min, Kim Yu Jung, Kim Se Hyun, Kim Jin Won, Lee Jeong-Ok, Han Jung Ho, Lee Keun-Wook, Kim Jee Hyun, Kim Chae-Yong, Bang Soo-Mee, Kim In-Ah, Kim Jae Sung, Lee Jong-Seok

  Salvage Treatment with Intracerebrospinal Fluid Thiotepa in Patients with Leptomeningeal Metastasis After Failure of Methotrexate-based Treatment

  ANTICANCER RES

  2015 ;35 (10) :5631 -5638

• Sim Sung Hoon, Lee Jong Seok, Kim Yu Jung, Kim Se Hyun, Keam Bhumsuk, Kim Tae Min, Lee Se-Hoon, Kim Dong-Wan, Heo Dae Seog

  Current status of chemotherapy use and clinical outcome in octogenarians with advanced non-small cell lung cancer

  J CANCER RES CLIN

  2015 ;141 (6) :1073 -1081

• Baek Seon Ha, Kim Se Hyun, Kim Jin Won, Kim Yu Jung, Lee Keun-Wook, Na Ki Young

  Effects of a DPP4 inhibitor on cisplatin-induced acute kidney injury: study protocol for a randomized controlled trial

  TRIALS

  2015 ;16

• Kim Jin Won, Kim Se-Hyun, Kim Yu Jung, Lee Keun-Wook, Kim Kwang-Il, Lee Jong Seok, Kim Cheol-Ho, Kim Jee Hyun,

  A Novel Geriatric Screening Tool in Older Patients with Cancer: The Korean Cancer Study Group Geriatric Score (KG)-7

  PLOS ONE

  2015 ;10 (9)

• Park Sehhoon, Keam Bhumsuk, Kim Se Hyun, Kim Ki Hwan, Kim Yu Jung, Kim Jin-Soo, Kim Tae Min, Lee Se-Hoon, Kim Dong-Wan, Lee Jong Seok, Heo Dae Seog

  Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR Mutations

  CANCER RES TREAT

  2015 ;47 (4) :630 -637

• Moon Sung-Ung, Kim Jin Won, Sung Ji Hea, Kang Mi Hyun, Kim Se-Hyun, Chang Hyun, Lee Jeong-Ok, Kim Yu Jung, Lee Keun-Wook, Kim Jee Hyun, Bang Soo-Mee, Lee Jong Seok

  p21-Activated Kinase 4 (PAK4) as a Predictive Marker of Gemcitabine Sensitivity in Pancreatic Cancer Cell Lines

  CANCER RES TREAT

  2015 ;47 (3) :501 -508

• Kim Ji-Yeon, Shin Eun, Kim Jin Won, Lee Hye Seung, Lee Dae-Won, Kim Se-Hyun, Lee Jeong-Ok, Kim Yu Jung, Kim Jee Hyun, Bang Soo-Mee, Ahn Sang-Hoon, Park Do Joong, Lee Jong Seok, Lee Ju-Seog, Kim Hyung-Ho, Lee Keun-Wook

  Impact of intratumoral expression levels of fluoropyrimidine-metabolizing enzymes on treatment outcomes of adjuvant S-1 therapy in gastric cancer

  PLOS ONE

  2015 ;10 (3)

• Lim Yoojoo, Lee Jeong-Ok, Kim Se Hyun, Kim Jin Won, Kim Yu Jung, Lee Keun-Wook, Lee Jong Seok, Bang Soo-Mee

  Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden

  THROMB RES

  2015 ;135 (5) :846 -851

• Lee Yoontaek, Kang Eunyoung, Lee Angela Soeun, Baek Hyunnam, Kim Eun-Kyu, Park So Yeon, Kim Jee Hyun, Kim Yu Jung, Kim Se Hyun, Kim In Ah, Eom Keun-Yong, Kim Sung-Won

  Outcomes and recurrence patterns according to breast cancer subtypes in Korean women

  BREAST CANCER RES TR

  2015 ;151 (1) :183 -190

저서 및 특허 ●